Skip to main content
IONS logo
IONS
(NASDAQ)
Ionis Pharmaceuticals, Inc.
$75.06-- (--)
Loading... - Market loading

Ionis Pharmaceuticals (IONS) Stock Price & Financial Analysis

Ionis Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$72.00 - $74.15
52-Week High$86.74
52-Week Low$32.00
Open$72.76
Volume1.50M
Average Volume (3M)1.78M
Market Cap12.18B
Shares Outstanding165.00M
Price to Sales (P/S)11.52
Price to Book (P/B)24.79
EV/EBITDA3.00
Revenue (TTM)1.06B
Net Income (TTM)-326.58M
Free Cash Flow (TTM)-970.78M
EPS (TTM)$-1.95
Profit Margin-30.87%
Operating Margin-33.35%
Return on Equity (ROE)-66.46%
Debt to Equity3.63
50-Day MA$74.36
200-Day MA$70.88
52-Week Change124.81%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateFeb 17, 2000

Frequently Asked Questions About Ionis Pharmaceuticals

What is the current stock price for IONS?

As of the latest trading session, IONS stock trades at $73.84. The 52-week range is $32.00–$86.74, with a day range of $72.00–$74.15.

What is the P/E ratio for IONS?

The P/E ratio (Price-to-Earnings) for IONS is shown in the Key Statistics section. This valuation metric helps compare Ionis Pharmaceuticals, Inc. to industry peers.

Does IONS pay dividends?

Ionis Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IONS?

Based on 10 analysts, the consensus for IONS is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IONS?

Ionis Pharmaceuticals's market capitalization is $12.18B, classifying it as a large-cap company. Ionis Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.